Roles of Sema4D and Plexin-B1 in tumor progression

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Ch'ng, Ewe Seng ^a   Kumanogoh, Atsushi ^b  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLEXIN; PLEXIN B1; SEMAPHORIN; SEMAPHORIN 4D; UNCLASSIFIED DRUG; CD100 ANTIGEN; CELL SURFACE RECEPTOR; LEUKOCYTE ANTIGEN; NERVE PROTEIN; PLXNB1 PROTEIN, HUMAN;

ANGIOGENESIS; ANTIGEN PRESENTING CELL; B CELL LEUKEMIA; B LYMPHOCYTE; BREAST CARCINOMA; CANCER CELL; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; NERVE FIBER; NERVOUS SYSTEM; OVARY CARCINOMA; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SOFT TISSUE SARCOMA; T LYMPHOCYTE; TUMOR MICROENVIRONMENT; ANIMAL; BIOLOGICAL MODEL; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; ANTIGENS, CD; HUMANS; MACROPHAGES; MODELS, BIOLOGICAL; NEOPLASMS; NERVE TISSUE PROTEINS; RECEPTORS, CELL SURFACE; SEMAPHORINS;

EID: 77956658813     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-251     Document Type: Review

References (49)

1. Goodman CS, Kolodkin AL, Luo Y, Püschel AW, Raper JA. Unified Nomenclature for the Semaphorins/Collapsins. Cell 1999, 97:551-552. 10.1016/S0092-8674(00)80766-7, 10367884.
2. Tamagnone L, Artigiani S, Chen H, He Z, Ming G, Song H, Chedotal A, Winberg ML, Goodman CS, Poo M, et al. Plexins Are a Large Family of Receptors for Transmembrane, Secreted, and GPI-Anchored Semaphorins in Vertebrates. Cell 1999, 99:71-80. 10.1016/S0092-8674(00)80063-X, 10520995.
3. Pasterkamp RJ, Giger RJ. Semaphorin function in neural plasticity and disease. Curr Opin Neurobiol 2009, 19:263-274. 10.1016/j.conb.2009.06.001, 2730419, 19541473.
4. Tran TS, Kolodkin AL, Bharadwaj R. Semaphorin Regulation of Cellular Morphology. Annu Rev Cell Dev Biol 2007, 23:263-292. 10.1146/annurev.cellbio.22.010605.093554, 17539753.
5. Mizui M, Kumanogoh A, Kikutani H. Immune Semaphorins: Novel Features of Neural Guidance Molecules. J Clin Immunol 2009, 29:1-11. 10.1007/s10875-008-9263-7, 19067132.
6. Neufeld G, Kessler O. The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer 2008, 8:632-645. 10.1038/nrc2404, 18580951.
7. Capparuccia L, Tamagnone L. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment - two sides of a coin. J Cell Sci 2009, 122:1723-1736. 10.1242/jcs.030197, 19461072.
8. Flannery E, Duman-Scheel M. Semaphorins at the interface of development and cancer. Curr Drug Targets 2009, 10:611-619.
9. Potiron VA, Roche J, Drabkin HA. Semaphorins and their receptors in lung cancer. Cancer Lett 2009, 273:1-14. 10.1016/j.canlet.2008.05.032, 2630718, 18625544.
10. Bougeret C, Mansur IG, Dastot H, Schmid M, Mahouy G, Bensussan A, Boumsell L. Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol 1992, 148:318-323.
11. Hall KT, Boumsell L, Schultze JL, Boussiotis VA, Dorfman DM, Cardoso AA, Bensussan A, Nadler LM, Freeman GJ. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci USA 1996, 93:11780-11785. 10.1073/pnas.93.21.11780, 38135, 8876214.
12. Furuyama T, Inagaki S, Kosugi A, Noda S, Saitoh S, Ogata M, Iwahashi Y, Miyazaki N, Hamaoka T, Tohyama M. Identification of a Novel Transmembrane Semaphorin Expressed on Lymphocytes. J Biol Chem 1996, 271:33376-33381. 10.1074/jbc.271.52.33376, 8969198.
13. Kumanogoh A, Watanabe C, Lee I, Wang X, Shi W, Araki H, Hirata H, Iwahori K, Uchida J, Yasui T, et al. Identification of CD72 as a Lymphocyte Receptor for the Class IV Semaphorin CD100: A Novel Mechanism for Regulating B Cell Signaling. Immunity 2000, 13:621-631. 10.1016/S1074-7613(00)00062-5, 11114375.
14. Ishida I, Kumanogoh A, Suzuki K, Akahani S, Noda K, Kikutani H. Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses. Int Immunol 2003, 15:1027-1034. 10.1093/intimm/dxg098, 12882840.
15. Kumanogoh A, Suzuki K, Ch'ng E, Watanabe C, Marukawa S, Takegahara N, Ishida I, Sato T, Habu S, Yoshida K, et al. Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells. J Immunol 2002, 169:1175-1181.
16. Delaire S, Billard C, Tordjman R, Chedotal A, Elhabazi A, Bensussan A, Boumsell L. Biological Activity of Soluble CD100. II. Soluble CD100, Similarly to H-SemaIII, Inhibits Immune Cell Migration. J Immunol 2001, 166:4348-4354.
17. Chabbert-de Ponnat I, Marie-Cardine A, Pasterkamp RJ, Schiavon V, Tamagnone L, Thomasset N, Bensussan A, Boumsell L. Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively. Int Immunol 2005, 17:439-447. 10.1093/intimm/dxh224, 15746246.
18. Herold C, Bismuth G, Bensussan A, Boumsell L. Activation signals are delivered through two distinct epitopes of CD100, a unique 150 kDa human lymphocyte surface structure previously defined by BB18 mAb. Int Immunol 1995, 7:1-8. 10.1093/intimm/7.1.1, 7718506.
19. Herold C, Elhabazi A, Bismuth G, Bensussan A, Boumsell L. CD100 is associated with CD45 at the surface of human T lymphocytes. Role in T cell homotypic adhesion. J Immunol 1996, 157:5262-5268.
20. Billard C, Delaire S, Raffoux E, Bensussan A, Boumsell L. Switch in the protein tyrosine phosphatase associated with human CD100 semaphorin at terminal B-cell differentiation stage. Blood 2000, 95:965-972.
21. Moreau-Fauvarque C, Kumanogoh A, Camand E, Jaillard C, Barbin G, Boquet I, Love C, Jones EY, Kikutani H, Lubetzki C, et al. The Transmembrane Semaphorin Sema4D/CD100, an Inhibitor of Axonal Growth, Is Expressed on Oligodendrocytes and Upregulated after CNS Lesion. J Neurosci 2003, 23:9229-9239.
22. Swiercz JM, Kuner R, Behrens J, Offermanns S. Plexin-B1 Directly Interacts with PDZ-RhoGEF/LARG to Regulate RhoA and Growth Cone Morphology. Neuron 2002, 35:51-63. 10.1016/S0896-6273(02)00750-X, 12123608.
23. Oinuma I, Ishikawa Y, Katoh H, Negishi M. The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 2004, 305:862-865. 10.1126/science.1097545, 15297673.
24. Kenta M, Tatsuo F, Mizue T, Shiho F, Hitomi K, Shinobu I. Sema4D stimulates axonal outgrowth of embryonic DRG sensory neurones. Genes Cells 2004, 9:821-829. 10.1111/j.1365-2443.2004.00766.x, 15330859.
25. Giacobini P, Messina A, Morello F, Ferraris N, Corso S, Penachioni J, Giordano S, Tamagnone L, Fasolo A. Semaphorin 4D regulates gonadotropin hormone-releasing hormone-1 neuronal migration through PlexinB1-Met complex. J Cell Biol 2008, 183:555-566. 10.1083/jcb.200806160, 2575794, 18981235.
26. Conrotto P, Valdembri D, Corso S, Serini G, Tamagnone L, Comoglio PM, Bussolino F, Giordano S. Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 2005, 105:4321-4329. 10.1182/blood-2004-07-2885, 15632204.
27. Basile JR, Barac A, Zhu T, Guan K-L, Gutkind JS. Class IV Semaphorins Promote Angiogenesis by Stimulating Rho-Initiated Pathways through Plexin-B. Cancer Res 2004, 64:5212-5224. 10.1158/0008-5472.CAN-04-0126, 15289326.
28. Basile JR, Gavard J, Gutkind JS. Plexin-B1 Utilizes RhoA and Rho Kinase to Promote the Integrin-dependent Activation of Akt and ERK and Endothelial Cell Motility. J Biol Chem 2007, 282:34888-34895. 10.1074/jbc.M705467200, 17855350.
29. Basile JR, Afkhami T, Gutkind JS. Semaphorin 4D/Plexin-B1 Induces Endothelial Cell Migration through the Activation of PYK2, Src, and the Phosphatidylinositol 3-Kinase-Akt Pathway. Mol Cell Biol 2005, 25:6889-6898. 10.1128/MCB.25.16.6889-6898.2005, 1190270, 16055703.
30. Ch'ng E, Tomita Y, Zhang B, He J, Hoshida Y, Qiu Y, Morii E, Nakamichi I, Hamada K, Ueda T, Aozasa K. Prognostic significance of CD100 expression in soft tissue sarcoma. Cancer 2007, 110:164-172. 10.1002/cncr.22764, 17520683.
31. Basile JR, Castilho RM, Williams VP, Gutkind JS. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci USA 2006, 103:9017-9022. 10.1073/pnas.0508825103, 1482558, 16754882.
32. Basile JR, Holmbeck K, Bugge TH, Gutkind JS. MT1-MMP Controls Tumor-induced Angiogenesis through the Release of Semaphorin 4D. J Biol Chem 2007, 282:6899-6905. 10.1074/jbc.M609570200, 17204469.
33. Sierra JR, Corso S, Caione L, Cepero V, Conrotto P, Cignetti A, Piacibello W, Kumanogoh A, Kikutani H, Comoglio PM, et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J Exp Med 2008, 205:1673-1685. 10.1084/jem.20072602, 2442644, 18559453.
34. Fazzari P, Penachioni J, Gianola S, Rossi F, Eickholt B, Maina F, Alexopoulou L, Sottile A, Comoglio P, Flavell R, Tamagnone L. Plexin-B1 plays a redundant role during mouse development and in tumour angiogenesis. BMC Dev Biol 2007, 7:55. 10.1186/1471-213X-7-55, 1890291, 17519029.
35. Trusolino L, Comoglio PM. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer 2002, 2:289-300. 10.1038/nrc779, 12001990.
36. Giordano S, Corso S, Conrotto P, Artigiani S, Gilestro G, Barberis D, Tamagnone L, Comoglio PM. The Semaphorin 4D receptor controls invasive growth by coupling with Met. Nat Cell Biol 2002, 4:720-724. 10.1038/ncb843, 12198496.
37. Conrotto P, Corso S, Gamberini S, Comoglio PM, Giordano S. Interplay between scatter factor receptors and B plexins controls invasive growth. Oncogene 2004, 23:5131-5137. 10.1038/sj.onc.1207650, 15184888.
38. Artigiani S, Barberis D, Fazzari P, Longati P, Angelini P, van de Loo J-W, Comoglio PM, Tamagnone L. Functional Regulation of Semaphorin Receptors by Proprotein Convertases. J Biol Chem 2003, 278:10094-10101. 10.1074/jbc.M210156200, 12533544.
39. Swiercz JM, Worzfeld T, Offermanns S. ErbB-2 and Met Reciprocally Regulate Cellular Signaling via Plexin-B1. J Biol Chem 2008, 283:1893-1901. 10.1074/jbc.M706822200, 18025083.
40. Swiercz JM, Kuner R, Offermanns S. Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2. J Cell Biol 2004, 165:869-880. 10.1083/jcb.200312094, 2172401, 15210733.
41. Oinuma I, Katoh H, Negishi M. Semaphorin 4D/Plexin-B1-mediated R-Ras GAP activity inhibits cell migration by regulating β1 integrin activity. J Cell Biol 2006, 173:601-613. 10.1083/jcb.200508204, 2063868, 16702230.
42. Wong OG, Nitkunan T, Oinuma I, Zhou C, Blanc V, Brown RS, Bott SR, Nariculam J, Box G, Munson P, et al. Plexin-B1 mutations in prostate cancer. Proc Natl Acad Sci USA 2007, 104:19040-19045. 10.1073/pnas.0702544104, 2141904, 18024597.
43. Deaglio S, Vaisitti T, Bergui L, Bonello L, Horenstein AL, Tamagnone L, Boumsell L, Malavasi F. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood 2005, 105:3042-3050. 10.1182/blood-2004-10-3873, 15613544.
44. Rody A, Karn T, Ruckhaberle E, Hanker L, Metzler D, Muller V, Solbach C, Ahr A, Gatje R, Holtrich U, Kaufmann M. Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis. Eur J Cancer 2009, 45:405-413. 10.1016/j.ejca.2008.10.016, 19054665.
45. Rody A, Holtrich U, Gaetje R, Gehrmann M, Engels K, von Minckwitz G, Loibl S, Diallo-Danebrock R, Ruckhaberle E, Metzler D, et al. Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1. Clin Cancer Res 2007, 13:1115-1122. 10.1158/1078-0432.CCR-06-2433, 17317819.
46. Gomez Roman JJ, Garay GO, Saenz P, Escuredo K, Sanz Ibayondo C, Gutkind S, Junquera C, Simon L, Martinez A, Fernandez Luna JL, Val-Bernal JF. Plexin B1 is downregulated in renal cell carcinomas and modulates cell growth. Transl Res 2008, 151:134-140.
47. Valente G, Nicotra G, Arrondini M, Castino R, Capparuccia L, Prat M, Kerim S, Tamagnone L, Isidoro C. Co-expression of plexin-B1 and Met in human breast and ovary tumours enhances the risk of progression. Cell Oncol 2009, 31:423-436.
48. Tong Y, Hota PK, Hamaneh MB, Buck M. Insights into Oncogenic Mutations of Plexin-B1 Based on the Solution Structure of the Rho GTPase Binding Domain. Structure 2008, 16:246-258. 10.1016/j.str.2007.12.012, 2358926, 18275816.
49. Argast GM, Croy CH, Couts KL, Zhang Z, Litman E, Chan DC, Ahn NG. Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells. Oncogene 2009, 28:2697-2709. 10.1038/onc.2009.133, 19483722.